Tick-derived amblyommin and method of antithrombin therapy
    8.
    发明授权
    Tick-derived amblyommin and method of antithrombin therapy 失效
    TICK-DERIVED AMBLYOMMIN AND METHOD OF ANTIROMBIN THERAPY

    公开(公告)号:US5093322A

    公开(公告)日:1992-03-03

    申请号:US360573

    申请日:1989-06-02

    摘要: The invention relates to a new active substance--amblyommin--for anticoagulant therapy and to a process for the isolation thereof from hard ticks. The isolated protein having a thrombin-inhibitory action has a molecular weight of 20000 to 30000 dalton, an isoelectric point between 5.05 and 5.65 and the partial amino acid sequencesIle-Leu-Phe-Thr-Gln-Gly-Asn-X-Gly-Glu-Leu-Glu-Asn-X-Phe-Glu-,Lys-Ile-Leu-Phe-X-Gln-Gly- andAla-Ser-Tyr-Ile-Val-X-Ser-Glu-Ser-Ile-Gln-Ile-Leu-X-Leu-Ser-Glu-Gly-Ile-in which each radical X can be identical or different and each represents a naturally occurring amino acid.

    摘要翻译: 本发明涉及用于抗凝治疗的新型活性物质 - 抗凝血酶活性物质,以及将其与硬蜱分离的方法。 具有凝血酶抑制作用的分离蛋白质的分子量为20000〜30000道尔顿,等电点为5.05〜5.65,部分氨基酸序列Ile-Leu-Phe-Thr-Gln-Gly-Asn-X-Gly- Glu-Leu-Glu-Asn-X-Phe-Glu-,Lys-Ile-Leu-Phe-X-Gln-Gly-和Ala-Ser-Tyr-Ile-Val-X-Ser-Glu-Ser- Gln-Ile-Leu-X-Leu-Ser-Glu-Gly-Ile-,其中每个基团X可以相同或不同,并且各自表示天然存在的氨基酸。